{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:38:04Z","timestamp":1790753884550,"version":"4.1.0"},"reference-count":26,"publisher":"EDP Sciences","issue":"8-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1051\/medsci\/2004208-9788","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T15:33:51Z","timestamp":1299339231000},"page":"788-792","source":"Crossref","is-referenced-by-count":9,"title":["L\u2019offre de tests de pr\u00e9disposition g\u00e9n\u00e9tique au cancer du sein ou de l\u2019ovaire en France"],"prefix":"10.1051","volume":"20","author":[{"given":"Christine","family":"Sevilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Bourret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nogu\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Moatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagay","family":"Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"le","family":"Groupe G\u00e9n\u00e9tique et Cancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Julian-Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2004,8,15]]},"reference":[{"key":"R1","unstructured":"Blumberg-Mokri M. Les inventions biotechnologiques.Biofutur2002; 218 : 42\u20133."},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Sobol H, Bignon YJ, Bonaiti C,et al.Four years analysis of cancer genetic clinics activity inFranceform1994 to 1997 : a survey on 801 patients.Dis Markers1999; 15 : 1\u201315.","DOI":"10.1155\/1999\/140498"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Miki Y, Swensen J, Shattuck-Eiders D,et al.A strong candidate for the breast and ovarian susceptibility gene BRCA1.Science1994; 266 : 66\u201371.","DOI":"10.1126\/science.7545954"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Wooster R, Bignell G, Lancaster J,et al.Identification of the breast cancer susceptibility gene BRCA2.Nature1995; 378 : 789\u201392.","DOI":"10.1038\/378789a0"},{"key":"R5","unstructured":"Expertise collective Inserm. Risques h\u00e9r\u00e9ditaires de cancer du sein et de l\u2019ovaire : quelle prise en charge ? Paris :Inserm, 1998 : 636 p."},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Eisinger F, Alby N, Bremond A,et al.Recommendations for medical management of hereditary breast and ovarian cancer : the French National Ad Hoc Committee.Ann Oncol1998; 9 : 939\u201350.","DOI":"10.1023\/A:1008389021382"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility.J Clin Oncol1996; 14 : 1730\u20136.","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Butler D, Goodman S. French researchers take a stand against cancer gene patent.Nature2001; 413 : 95\u20136.","DOI":"10.1038\/35093217"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Benowitz S. French challenge to BRCA1 patent underlies European discontent.J Natl Cancer Inst2002; 94 : 80\u20131.","DOI":"10.1093\/jnci\/94.2.80"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Wadman M. Testing time for gene patent as Europe rebels.Nature2001; 413 : 443.","DOI":"10.1038\/35097228"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Sevilla C, Julian-Reynier C, Eisinger F,et al.The impact of gene patents on the cost-effective delivery of care : The case of BRCA1 genetic testing. IntJ Technol Assess Health Care2003; 19 : 287\u2013300.","DOI":"10.1017\/S0266462303000266"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Sevilla C, Moatti JP, Julian-Reynier C,et al.Testing for BRCA1 mutations : A cost-effectiveness analysis.Eur J Hum Genet2002; 10 : 599\u2013606.","DOI":"10.1038\/sj.ejhg.5200854"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Brower V. Testing, testing\u2026 testing ?Nat Med1997; 3 : 131\u20132.","DOI":"10.1038\/nm0297-131"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Kaufert PA. Health policy and the new genetics.Soc Sci Med2000; 51 : 821\u20139.","DOI":"10.1016\/S0277-9536(00)00063-0"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Reynolds T. NCI-Myriad agreement offers BRCA testing at reduced cost.J Natl Cancer Inst2000; 92 : 596.","DOI":"10.1093\/jnci\/92.8.596"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Hollon T. NIH researchers receive cut-price BRCA test.Nat Med2000; 6 : 610.","DOI":"10.1038\/76149"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Cassier M, Gaudilli\u00e8re JP. Recherche, m\u00e9decine et march\u00e9 : la g\u00e9n\u00e9tique du cancer du sein.Sci Soc Sant\u00e92000; 18 : 29\u201349.","DOI":"10.3406\/sosan.2000.1504"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Gold ER, Caulfield TA. The moral tollbooth : A method that makes use of the patent system to address ethical concerns in biotechnology.Lancet2002; 359 : 2268\u201370.","DOI":"10.1016\/S0140-6736(02)09298-X"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Zick CD, Smith KR, Mayer RN, Botkin JR. Genetic testing, adverse selection, and the demand for life insurance.Am J Med Genet2000;93 : 29\u201339.","DOI":"10.1002\/1096-8628(20000703)93:1<29::AID-AJMG6>3.3.CO;2-B"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Hoel M, Iversen T. Genetic testing when there is a mix of compulsory and voluntary health insurance.J Health Econ2002; 21 : 253\u201370.","DOI":"10.1016\/S0167-6296(01)00112-6"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Strohmenger R, Wambach A. Adverse selection and categorical discrimination in the health insurance markets: the effects of genetic tests.J Health Econ2000; 19 : 197\u2013218.","DOI":"10.1016\/S0167-6296(99)00021-1"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"C;ller H. Genetic testing for cancer predisposition-an ongoing debate.Lancet Oncol2000; 1 : 118\u20139.","DOI":"10.1016\/S1470-2045(00)00082-6"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Matloff ET, Shappell H, Brierley K,et al.What would you do ? Specialists\u2019 perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.J Clin Oncol2000; 18 : 2484\u201392.","DOI":"10.1200\/JCO.2000.18.12.2484"},{"key":"R24","unstructured":"Peterson EA, Milliron KJ, Lewis KE,et al.Health insurance and discrimination concerns and BRCA1\/2 testing in a clinic population. Cancer EpidemiolBiomarker Prev2002; 11 : 79\u201387."},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Julian-Reynier C, Sobol H, Sevilla C,et al.Uptake of hereditary breast\/ovarian cancer genetic testing in a French national sample of BRCA1 families.Psycho- Oncology2000; 9 : 504\u201310.","DOI":"10.1002\/1099-1611(200011\/12)9:6<504::AID-PON491>3.0.CO;2-R"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Julian-Reynier C, Eisinger F, Chabal F,et al.Disclosure to the family of breast\/ovarian cancer genetic test results : patient\u2019s willingness and associated factors. AmJ Med Genet2000; 94 : 13\u20138.","DOI":"10.1002\/1096-8628(20000904)94:1<13::AID-AJMG4>3.0.CO;2-T"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004208-9788\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T01:32:31Z","timestamp":1560043951000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004208-9788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":26,"journal-issue":{"issue":"8-9"},"alternative-id":["medsci2004208-9p788"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2004208-9788","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}